In this issue

Issue 34 • December 2020

As we head towards the new year, its hard not to look back at what has been a challenging year for the medical technology industry. While the results of multiple Covid-19 vaccine trials suggest that the preliminary challenges of this pandemic may be on the way out, new issues, such as long-term Covid symptoms, look set to create new hurdles for the industry moving forward.

The idea of overcoming severe long-term physical symptoms is something that Dr Peter Scott-Morgan is very familiar with. After receiving a terminal motor-neuron disease diagnosis in 2017, he began his pursuit of a way to defeat the condition – using technology to combat the physical limitations that come hand-in-hand with the disease.

Three years on, Scott-Morgan is well on his way to becoming the first human cyborg thanks to a range of innovative technologies that could spell change for a patient demographic that is often left behind. To find out what this venture could mean for the future of motor neuron disease treatment, we take a look at Scott-Morgan’s efforts and the technologies being used to help improve his quality of life.

Plus, we examine calls for a materials revolution in healthcare tech, debate whether biobanks should be obliged to inform patients if undiagnosed conditions are uncovered during research, find out how technology is helping to transform communication in clinical settings and much more.

As always, stay safe.

Eloise Mclennan, editor

Go to article: Home | Becoming the first human cyborgGo to article: In this issueGo to article: ContentsGo to article: Formacoat Company InsightGo to article: FormacoatGo to article: uvexGo to article: BriefingGo to article: Industry newsGo to article: Covid-19 executive briefing by GlobalDataGo to article: The medical industry briefingGo to article: Industrial Indexing Systems Company InsightGo to article: Industrial Indexing SystemsGo to article: ElectroCraftGo to article: KSP Go to article: Electronic Sensor TechnologyGo to article: CommentGo to article: Robotics in medtech industry primed for significant growth to end bumpy 2020Go to article: AI-powered platforms expand further into traditional healthcareGo to article: Penumbra’s Indigo Aspiration System expected to continue dominating US marketGo to article: Early on, 5G is already making an impact and demonstrating its potentialGo to article: ENT market on course for full recovery following year disrupted by Covid-19Go to article: Research Collective Company Insight Go to article: Research CollectiveGo to article: Repsol Go to article: SartoriusGo to article: Peak Performance Compounding Go to article: In DepthGo to article: The ins and outs of the SABA asthma inhalerGo to article: Can you hear me now? The tech transforming clinical communicationGo to article: Should biobanks release diagnostic data to patients?Go to article: Inside the mission to become the first cyborgGo to article: Miracle metal: could copper clothing help fight infection?Go to article: LexaGene’s new automated testing platformGo to article: Recurrent fainting: could a new pacemaker provide a solution?Go to article: Kickstarting AI and smart data in resource-limited health systemsGo to article: BioInteractions Company Insight Go to article: BioInteractions Go to article: Sandvik Company InsightGo to article: Sandvik Go to article: ICF MercantileGo to article: In DataGo to article: Inside the dealGo to article: Deals analysisGo to article: The medical industry key listGo to article: Global markets and indicesGo to article:  Macro-economic indicatorsGo to article: Macro-economic indicators (page 2)Go to article: Fisba Go to article: INDO-MIMGo to article: AccumoldGo to article: GS SwissGo to article: oncgnosticsGo to article: EventsGo to article: Next issueGo to article: CODIXX Go to article: Alicona ImagingGo to article: RETERO Go to article: CoherentGo to article: Eastprint Incorporated